SUMMAR, Marshall L.,CHRISTMAN, Brian,BARR, Frederick E.
申请号：
AU2015202185
公开号：
AU2015202185A2
申请日:
2015.04.29
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015202185A220150528.pdf#####ABSTRACT Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I 5 phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the 10 context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants. 6424294_1 (GHMatters) P61593.AU.3 PETERB 24104/151/13 Mitochondria HCO3 +NH4+ ATP S CPSI - Nacetylglutamate Carbamyl Aspartic Phosphate OTC Acid Ontie Citrulline CitrullineZ As Ornithine Arginosuccinate ARArginine S Urea Fumorate FIGo I ATP(O HCO3 Caramat z~a:: " o Cabam0 ADP Crbaml Phopha0 /abx Phsht/ NH3 D FI,
